ChromoTek V5-Trap for the isolation of V5-tagged proteins
01 October, 2021ChromoTek has introduced the V5-Trap, which is a Nanobody or VHH coupled to agarose, magnetic agarose and magnetic beads for immunoprecipitation (IP) and co-IP of V5-tagged proteins.
GenScript COVID-19 virus antigens and antibodies
23 September, 2021GenScript has developed a comprehensive range of products that scientists may use to accelerate COVID-19 research and development.
ProSci single-domain antibodies
06 September, 2021ProSci's sdAb products are designed to introduce a further capability to research regimens in the areas of immuno-oncology and immune checkpoints in addition to SARS-CoV-2 Spike.
Monoclonal antibody prevents malaria in small trial
18 August, 2021One dose of a new monoclonal antibody safely prevented malaria for up to nine months in people who were exposed to the malaria parasite.
GeneTex zebrafish antibodies
05 August, 2021The antibodies have been tested on zebrafish samples in a variety of applications including, but not limited to, immunofluorescence, immunohistochemistry and western blot.
ChromoTek Nano-Traps with Nanobodies
01 August, 2021Available from ChromoTek are three Nano-Traps with the Nanobody coupled to the Magnetic Particles M-270. These are the GFP-Trap, RFP-Trap and Spot-Trap.
GeneTex recombinant antibodies
03 June, 2021GeneTex offers over 300 recombinant antibodies for research into SARS-CoV-2, apoptosis, immune checkpoints, cytoskeleton, JNK signalling and more.
ProSci cytokine storm research antibodies and proteins
04 May, 2021The cytokine storm is still a relatively recent discovery, scientifically speaking, and is actively being studied. ProSci enhances this type of research through supplying high-performance antibodies and recombinant proteins for investigating IFNs, ILs, TNF, chemokines, CSF and growth factors.
The Native Antigen Company recombinant SARS-CoV-2 spike mutants
01 May, 2021To support the investigation of SARS-CoV-2 variants, The Native Antigen Company offers a growing range of recombinant mutant spike antigens.
Tick-transmitted brain disease may be treatable
15 April, 2021Researchers have found antibodies capable of neutralising tick-borne encephalitis (TBE), a viral infectious disease transmitted by tick bites.
Aves Labs anti-green fluorescent protein antibody
14 April, 2021Aves Labs' anti-green fluorescent protein antibody (GFP) is a highly cited chicken polyclonal antibody, having gained over 1300 citations worldwide.
Abcam recombinant antibodies
17 March, 2021Abcam's recombinant antibodies overcome the limitations of traditional antibody production to provide a high level of consistency between batches, reproducibility, confirmed specificity and a long-term supply.
AdipoGen Life Sciences APO-1-3 and APO-1-1 apoptosis-inducing antibodies
16 February, 2021AdipoGen Life Sciences' anti-Fas clones APO-1-3 and APO-1-1 are monoclonal antibodies that recognise human Fas and are capable of inducing Fas-mediated apoptosis.
Cancer drug delivered on a MOF
15 February, 2021Loading a cancer immunotherapy drug onto a metal–organic framework improves both its delivery and its sustained release for treating leukaemia.
Researchers fast-track antibody development
10 February, 2021Researchers have developed a method that fast-tracks the passage of biopharmaceuticals from the lab to clinical trials — from as long as two years to just six months.
